Shedding of Vaccine Viruses with Increased Antigenic and Genetic Divergence after Vaccination of Newborns with Monovalent Type 1 Oral Poliovirus Vaccine

For the final stages in the eradication of poliovirus type 1 (P1), the World Health Organization advocates the selective use of monovalent type 1 oral poliovirus vaccine (mOPV1). To compare the immunogenicity of mOPV1 with that of trivalent OPV (tOPV) in infants, a study was performed in Egypt in 20...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: van der Sanden, Sabine, Pallansch, Mark A., van de Kassteele, Jan, El-Sayed, Nasr, Sutter, Roland W., Koopmans, Marion, van der Avoort, Harrie
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2009
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738206/
https://ncbi.nlm.nih.gov/pubmed/19515771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02388-08
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars